Oct 29, 2026 · 56 min
Whoop bets continuous health data can outpace traditional testing
WHOOP CEO, Will Ahmed: 50B Hours of Health Data, a 4 Million Member Data Moat, & the FDA Fight
The conversation examines whether a subscription wearable can turn continuous physiological data into useful health guidance while navigating medical regulation and Big Tech competition.
- 1Whoop built a subscription business around continuous monitoring, using sleep, recovery, strain, and HRV to drive engagement and retention.
- 2Its next ambition is to combine wearable signals with journals, blood tests, and medical records to develop more personalized AI coaching.
- 3FDA strategy and competition from Apple and Google expose the tension between wellness convenience, clinical credibility, and screen-free design.
Don't miss
Will Ahmed explains how Whoop’s 50 billion hours of physiological data could train AI models that combine wearable signals with blood tests and medical records.
The brief
Will Ahmed traces Whoop’s shift from expensive hardware to subscriptions, arguing that recurring revenue makes engagement, retention, and product effectiveness central to the business.
The company’s core promise rests on continuous sleep, recovery, strain, and HRV tracking, with the Journal linking everyday behaviors to measurable changes in recovery.
Ahmed says more than 50 billion hours of physiological data could support AI models that combine wearable signals with blood tests, medical records, and other inputs.
The FDA discussion reveals Whoop’s balancing act: preserve a wellness product’s accessibility while pursuing medically cleared features such as ECG and blood-pressure measurement.
LeBron James’s ambassador role underscores the company’s preference for long-term organic adoption, after eleven years of using Whoop before the formal partnership.
The larger bet is that a screen-free subscription can compete with Apple and Google by making continuous health data useful without turning the wrist into another display.
What was said on this episode
32 statements · 25 positive · 6 negative · 1 neutral
Whoop has over 50 billion hours of physiological data, making it one of the world’s largest health datasets.
“We have just over 50 billion hours of continuous physiological data. So it's one of the largest health data sets in the world.”
Listen at 0:05
Physiological signals may predict abnormal biomarkers without directly measuring those biomarkers.
“Through physiological signals, we might be able to predict that a biomarker is out of range without actually measuring the biomarker itself.”
Listen at 0:27
Whoop expects to end the year with approximately four million members.
“expect to end the year around 4 million members.”
Listen at 2:23
Whoop’s subscription model immediately drove substantial growth in 2018 and 2019.
“that immediately created all kinds of growth for Whoop back in 2018 and 19.”
Listen at 4:19
Whoop intends to launch hardware only when it is substantially more innovative.
“We want to launch hardware when it's really innovative and it's a step function better.”
Listen at 5:57
Whoop’s existing hardware supports ECG, AFib detection, labs, health-span, and daily blood-pressure features.
“ECG monitoring or AFib detection or advanced labs, which is now the blood work feature that we have in the app or health span, which tells you your whoop age and is a whole longevity feature. Blood pressure insights, which is a new capability that allows people to look at their blood pressure every day.”
Listen at 6:14
A two-breath increase in respiratory rate is meaningful because respiratory rate normally changes little.
“when your respiratory rate is elevated by two breaths like that, that's actually pretty meaningful because respiratory rate is normally a very boring statistic. It normally doesn't change at all.”
Listen at 10:48
A member’s abnormal sleeping heart rate preceded diagnosis of stage-four Hodgkin lymphoma.
“Someone with a resting heart rate of 50 beats per minute getting a heart rate of 120, 130 while he's sleeping. And he goes in to see the doctor and they do some tests and sure enough, stage four Hodgkin lymphoma.”
Listen at 13:39
Greater heart-rate variability indicates healthier overall system operation.
“the more variability in time between successive beats of the heart, the healthier your overall system is operating.”
Listen at 14:34
Whoop measures heart-rate variability continuously.
“we're measuring heart rate variability 24-7.”
Listen at 15:27
Heart-rate variability is an important indicator of longevity.
“It's a really important longevity indicator.”
Listen at 16:12
Maintaining heart-rate variability over years signals good fitness and longevity.
“if you can fight that trend, that those averages and keep your heart rate variability even just flat over years, that's actually a sign of good fitness, good longevity.”
Listen at 16:36
The average Whoop member wears the device 23.6 hours daily.
“On average, a WHOOP member wears WHOOP 23.6 hours a day.”
Listen at 19:14
Whoop may predict abnormal biomarkers without directly measuring them.
“we might be able to predict that a biomarker is out of range without actually measuring the biomarker itself.”
Listen at 20:26
Whoop could identify likely high cortisol and recommend a targeted test.
“we think you have high cortisol, you should get this one test.”
Listen at 20:38
Whoop’s AI coach will be an important part of the company’s future.
“the AI coach is a big part of that. And it's a big part of our future.”
Listen at 22:55
More than half of Whoop members journal daily.
“Just over 50% of our members journal every day.”
Listen at 23:43
Eating within three hours of bedtime harms sleep and recovery across the observed population.
“eating within three hours of bedtime, we've now seen across the entire population, is really detrimental to your sleep and your recovery.”
Listen at 28:01
Whoop invented its stress score.
“The stress score itself is something that we invented.”
Listen at 29:42
People taking GLP-1 drugs typically lose approximately equal amounts of fat and muscle.
“typically speaking, about 50% of the weight that someone loses is fat and 50% muscle.”
Listen at 33:07
Whoop’s blood-pressure insights feature remains available to consumers.
“our blood pressure insights feature is still available for consumers.”
Listen at 40:33
Whoop’s wrist ECG feature is FDA-cleared under the 510(k) pathway.
“we have these conversations with the FDA across a lot of different categories. WHOOP also has medical clearances from the FDA. So our ECG feature, where you can literally do an ECG from your wrist by just putting your fingers on the WHOOP, that's an FDA-cleared product, 510K.”
Listen at 40:39
Whoop does not sell user data.
“we do not sell data.”
Listen at 42:52
Many companies have struggled to build screenless or other wearable products.
“a lot of companies have entered our space and had challenges with the screenless wearable or other wearable products.”
Listen at 44:03
Daily cold showers lasting 30–60 seconds will make people feel better.
“it's something that people can do every day. And you do it for even 30 seconds, 60 seconds. You're just going to feel a lot better.”
Listen at 45:11
People should prioritize weightlifting over elliptical exercise when time is limited.
“everyone should be lifting more weights and probably doing, you know, if they have an hour to exercise, they should spend more time lifting and less time on an elliptical.”
Listen at 45:53
Muscle mass is an important indicator of longevity.
“your muscle mass is such an important test for longevity.”
Listen at 46:05
People running tech companies should use a fixed wake-up time rather than recovery-based alarms.
“If you're on vacation, you can go with recovery or sleep. But if you're trying to run a tech company, you better pick an exact time.”
Listen at 46:31
LeBron James has become a global ambassador for Whoop.
“LeBron James is now a global ambassador for Whoop.”
Listen at 47:43
Companies should prioritize authentic product adoption over paying users to promote products.
“You want people to love your product authentically.”
Listen at 49:31
Investors should obtain company CFO approval before conducting secondary transactions.
“just build a relationship with the CFO of the company and just get their blessing for it and let them know what you're doing.”
Listen at 53:32
Some secondary brokers falsely claim to possess shares available at a stated price.
“these secondary brokers who they claim they've got shares from someone at a price.”
Listen at 53:50
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.